Genetic association mapping is a powerful tool to detect susceptibility genes for complex disorders, even when each of these genes has small contribution to risk. Given the lack of Consistency across studies, particularly of psychiatric diseases, it is imperative to develop and agree upon standards for the design and report of genetic association studies. The authors propose standards of general study design, diagnostic assessment, genotyping, and statistical analysis, which could enhance the comparability of future genetic association studies.
FEATURE ARTICLE
Affective disorders, antidepressant drugs and brain metabolism A Moretti, A Gorini, RF Villa This critical review looks closely at the role of energytransducing neuronal pathways in affective disorders and depression, examining the links between the molecular mechanisms and the bioenergetic systems that are severely compromised by these diseases. Based on the analysis of experimental and clinical publications, the authors aim to clarify the molecular basis of psychiatric diseases and assess the actions of drugs on energy metabolism in humans, in the perspective of a neuropharmacological approach for therapies of affective disorders and depression.
ORIGINAL RESEARCH ARTICLE
Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms EM Hol, RF Roelofs, E Moraal, MAF Sonnemans, JA Sluijs, EA Proper, PNE de Graan, DF Fischer,
FW van Leeuwen
The authors searched for the occurrence of frameshift mutations in glial fibrillary acidic protein (GFAP) mRNA in the hippocampus of nondemented controls, epilepsy patients, Alzheimer patients and Down syndrome patients. Three novel splice forms of GFAP were found to be expressed, two of which resulted in an out-of-frame carboxy-terminus. Expression of the glia-specific protein GFAP in neurons in patients with Alzheimer pathology was unexpected and might reflect a retro-differentiation of these neurons into multi-potent stem cells.
Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development ND Halim, C Shannon Weickert, BW McClintock, TM Hyde, DR Weinberger, JE Kleinman, BK Lipska
The authors examined the immunoreactivity of synapse-associated proteins (VAMP, syntaxin, synaptophysin, SNAP-25, synaptobrevin, GAP-43) in the prefrontal cortex of patients with schizophrenia and in neonatally hippocampally lesioned rats, and tested the stability of these proteins across postmortem intervals in rat brains. VAMP immunoreactivity was lower in the schizophrenic patients and higher in the lesioned rats. There were no differences in the immunoreactivity of any other proteins measured in schizophrenic patients as compared to the matched controls.
Abnormalities of myelination in schizoprenia detected in vivo with MRI, and postmortem with analysis of oligodendrocyte proteins SW Flynn, DJ Lang, AL Mackay, V Goghari, IM Vavsour, KP Whittall, GN Smith, V Arango, JJ Mann, Aj Dwork, P Falkai, Wg Honer Pathways of nerve cell communication depend on myelin to ensure information is transmitted quickly and accurately. The authors used magnetic resonance imaging to measure myelin, and found overall 12% lower myelin signal in schizophrenia compared with healthy subjects. Proteins related to myelin were also decreased as much as 33% in samples obtained after death in a different group of patients. Impairment in myelin could contribute to persistent functional impairment in patients with schizophrenia.
Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis SL Eastwood, PJ Harrison Schizophrenia may be a neurodevelopmental disorder, a view supported by reports of reduced expression of the gene reelin, and an altered distribution of white matter neurons. In the superior temporal lobe, Eastwood and Harrison report that in schizophrenia, these neurons express less reelin mRNA. Additionally, their density is increased in the superficial white matter. The study thus provides additional evidence for an involvement of reelin and white matter neurons in schizophrenia, and suggests a connection between these potential pathogenic processes.
Evidence for allelic association on chromosome 3q25-27 in families with autism spectrum M Auranen, T Varilo, R Alen, R Vanhala, K Ayers, E Kempas, T Ylisaukko-oja, L Peltonen, I Järvelä
The etiology of autism spectrum disorders is thought to be complex. To maximize genetic and cultural homogeneity, 31 families with autism and Asperger syndrome originating from a subisolate to Finland were studied. Association studies were performed on three chromosomal regions: 7q (AUTS1), 3q (AUTS2) and 1q. The association on chromosome 3q25-27 region was more significant in the subisolate compared to the families from the rest of Finland with linkage disequilibrium extending B20 cM in all families.
